The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells

JC Henquin - Diabetes research and clinical practice, 2011 - Elsevier
JC Henquin
Diabetes research and clinical practice, 2011Elsevier
This review outlines the two pathways that interact in β-cells to ensure temporal and
amplitude control of insulin secretion by glucose. The most well known triggering pathway
involves the following steps: acceleration of glucose metabolism, closure of ATP-sensitive
potassium channels, depolarization, influx of Ca2+ through voltage-gated calcium channels,
and a rise in the concentration of cytosolic ionized Ca2+ that triggers exocytosis of insulin-
containing granules. This classic sequence is, however, incomplete. Additional …
This review outlines the two pathways that interact in β-cells to ensure temporal and amplitude control of insulin secretion by glucose. The most well known triggering pathway involves the following steps: acceleration of glucose metabolism, closure of ATP-sensitive potassium channels, depolarization, influx of Ca2+ through voltage-gated calcium channels, and a rise in the concentration of cytosolic ionized Ca2+ that triggers exocytosis of insulin-containing granules. This classic sequence is, however, incomplete. Additional mechanisms, involving other channels, are necessarily implicated in the production of the triggering Ca2+ signal. It is also clear that the effect of glucose on insulin secretion would be poor if Ca2+-induced exocytosis was not markedly augmented (approximately doubled) through a metabolic amplifying pathway, mechanistically distinct from neurohormonal amplifying pathways. This metabolic amplifying pathway is physiologically relevant for both phases of glucose-induced insulin secretion and for the potentiation, by glucose, of insulin secretion triggered by non-metabolized secretagogues (e.g. arginine). Three important challenges for future studies will be to identify the additional targets mediating control of the triggering Ca2+ signal by glucose, to elucidate the cellular mechanisms of the metabolic amplifying pathway and to determine the contribution of each pathway in the alterations of insulin secretion in type 2 diabetic patients.
Elsevier